Sun Pharmaceuticals Industries announced that one of its wholly-owned subsidiaries has entered into an exclusive patent licensing agreement with H Lundbeck AS Lundbeck to market and distribute its own version of Vortioxetine in India under the brand name VORTIDIFtrade; The territory of the licensing agreement will only cover India Vortioxetine is a novel antidepressant with multimodal activity which is approved to treat Major Depressive Disorder MDD in adults The product is approved in over 80 countries including the US EU Canada and Australia
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
